Compare PRAX & BLDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | BLDR |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.5B |
| IPO Year | 2020 | 2005 |
| Metric | PRAX | BLDR |
|---|---|---|
| Price | $327.25 | $66.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 21 | 24 |
| Target Price | ★ $650.00 | $67.45 |
| AVG Volume (30 Days) | 420.7K | ★ 2.8M |
| Earning Date | 11-09-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $15,190,638,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $41,442.59 | N/A |
| P/E Ratio | ★ N/A | $782.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $160.11 | $49.67 |
| 52 Week High | $392.70 | $131.50 |
| Indicator | PRAX | BLDR |
|---|---|---|
| Relative Strength Index (RSI) | 63.91 | 59.38 |
| Support Level | $307.93 | $65.91 |
| Resistance Level | $347.63 | $78.13 |
| Average True Range (ATR) | 16.67 | 3.29 |
| MACD | 5.68 | 1.08 |
| Stochastic Oscillator | 96.95 | 76.79 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.